Categories AlphaGraphs, Earnings, Leisure & Entertainment
Earnings Preview: another dismal sales time for toymaker Hasbro in Q4
Toymaker Hasbro, Inc. (HAS) is expected to report its fourth-quarter 2018 earnings on Feb. 8, before the opening bell.
It was only a quarter ago that Hasbro missed estimates sending the stock down. This time, the Street expects earnings much lower at $1.68 a share on revenue of $1.52 billion.
Hasbro Q4 Earnings: stock slides as Toys ‘R’ Us shutdown hits holiday sales
This drop in estimates is on the assumption that the entire sector of traditional toymakers has been suffering from sliding consumer demand and a corresponding sales crunch.
Optimistically, fourth-quarter earnings are usually marginally better due to the inclusion of holiday sales, but the latest trend that retailers have reported could push Hasbro and other toymakers down further.
The liquidation of retailers such as Toys ‘R’ Us did not help either.
The maker of famous brands such as NERF and TRANSFORMERS and board games such as Monopoly, Hasbro has always been an industry giant. But the company is forced to diversify into tech-based products to tackle the latest taste of youngsters.
New offerings of video games, MP3 players, tablets, smartphones and other electronic devices have put pressure on both top-line and bottom-line by driving costs higher, and it might take a few more quarters for Hasbro to recover.
LOOKING BACK
In the previously reported third quarter, cost of sales for the toymaker shot up 100 basis points to 41.8% of net revenue, while operating margin slipped 10 basis points year-on-year.
Revenues then declined 12% on loss of sales from Toys ‘R’ Us the US, Europe and Asia-Pacific. Net income also dropped 1.4%, despite a favorable tax benefit from the US tax reform.
With changing retail landscapes, it is imperative for old-timers such as Hasbro to look to new avenues. Investors this time would be on the lookout of such ventures when the toy giant reports results on Friday.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on